Based on the demonstrated potential of laser-induced vapor nanobubbles to treat bacterial biofilm infections, we provide recommendations for future work in order to further mature this new technology into a promising anti-biofilm approach.
Scientists have created the world’s first living organism that has a synthetic and altered genetic code, built on only 61 codons as opposed to 64.
A new anaerobic organ-on-a-chip model has been demonstrated to support a complex community of gut microbes under low-oxygen conditions. This model of the microbiome could open opportunities for drug testing and development.
New research describes the use of small-molecule CD4 mimetic compounds that force HIV to undergo conformational changes, exposing normally hidden parts of the envelope and potential new targets.
A computer-aided model that uses routinely collected data could identify the early symptoms of sepsis, according to new research.
Want to discover the best research that’s occurred this year? Editor, Martha Powell, highlights the best of 2018’s infectious diseases research in an A–Z.
Researchers from the Center for Infection and Immunity have made a major breakthrough in diagnoses of pathogenic bacteria with their design, the BacCapSeq platform. It’s the first precision medicine platform to allow simultaneous screening for all known bacterial pathogens, as well as markers for antibiotic resistance and virulence.
Researchers from Purdue University have reported that antimicrobial photodynamic therapy using a fluorescent analog of heme, could be an alternative for treating MRSA infections.
Genomics – the study of the structure and function of genetic material in a cell – has caused somewhat of a revolution in microbiology in recent years, but when did the story start?
From antibiotic susceptibility testing to new instruments to screen for antibiotics, 3D printing is contributing to research on antimicrobial resistance.
